Tsuji Taishi, Yoon Jieun, Kitano Naruki, Okura Tomohiro, Tanaka Kiyoji
Center for Preventive Medical Sciences, Chiba University, 1-8-1 Inohana, Chuo Ward, Chiba City, Chiba, 260-8670, Japan.
Doctoral Program in Physical Education, Health and Sport Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba City, Ibaraki, 305-8574, Japan.
Aging Clin Exp Res. 2016 Apr;28(2):197-205. doi: 10.1007/s40520-015-0412-6. Epub 2015 Jul 16.
There was no evidence of satisfying the standard to decide the efficacies of glucosamine and chondroitin in middle-aged and older Japanese adults with knee pain and/or stiffness.
To investigate the effects of 24 week oral N-acetyl glucosamine and chondroitin sulfate supplementation on knee pain, self-reported knee function, physical activity, and physical performance.
We randomly assigned 11 men and 39 women (aged 52-87 years) to receive 100 mg of N-acetyl glucosamine and 180 mg of chondroitin sulfate daily (Glu/Cho group) or a placebo (control, C group) for 24 weeks. The primary outcomes were a 100 mm visual analog pain scale (VAS) and the Japanese Knee Osteoarthritis Measure (JKOM) score. The secondary outcomes were physical activity and physical performance.
We observed a significant group × time interaction on the JKOM score. According to the post hoc test, it significantly decreased (i.e., improved knee function) from the 4- to 12-week follow-up in the Glu/Cho group and the Glu/Cho group score was significantly lower than the C group at the 12-week follow-up. We found a significant interaction on household physical activity. There was no significant interaction on VAS or physical performance tests.
The results of the present study were consistent with previous studies mainly conducted in European and American countries.
These results suggest that consumption of N-acetyl glucosamine and chondroitin sulfate for 12 weeks or longer has a positive effect on self-reported knee function and household physical activity in middle-aged and older Japanese adults with knee pain and/or stiffness.
在日本中老年膝关节疼痛和/或僵硬患者中,尚无证据表明氨基葡萄糖和硫酸软骨素符合疗效判定标准。
研究口服N-乙酰氨基葡萄糖和硫酸软骨素24周对膝关节疼痛、自我报告的膝关节功能、身体活动和身体机能的影响。
我们将11名男性和39名女性(年龄52 - 87岁)随机分为两组,一组每天服用100毫克N-乙酰氨基葡萄糖和180毫克硫酸软骨素(氨基葡萄糖/软骨素组,Glu/Cho组),另一组服用安慰剂(对照组,C组),为期24周。主要结局指标为100毫米视觉模拟疼痛量表(VAS)和日本膝关节骨关节炎测量量表(JKOM)评分。次要结局指标为身体活动和身体机能。
我们观察到JKOM评分存在显著的组×时间交互作用。根据事后检验,Glu/Cho组在第4至12周随访时JKOM评分显著降低(即膝关节功能改善),且在第12周随访时Glu/Cho组评分显著低于C组。我们发现家庭身体活动存在显著交互作用。在VAS或身体机能测试方面未发现显著交互作用。
本研究结果与之前主要在欧美国家进行的研究一致。
这些结果表明,对于日本中老年膝关节疼痛和/或僵硬患者,服用N-乙酰氨基葡萄糖和硫酸软骨素12周或更长时间对自我报告的膝关节功能和家庭身体活动有积极影响。